Anadolu Medical Center
トルコにおける腫瘍治療の費用は、通常 $11,000 から $42,000 です。総費用は、がんの種類・病期、および外科手術や全身療法などの必要な治療様式によって異なります。国際的に認定された医療機関での治療を受けながら、米国と比較して50〜80％の費用削減が可能であると、海外からの患者に広く認識されています。
トルコにおける腫瘍治療の標準的な費用
主要な腫瘍診療拠点は、イスタンブール、アンカラ、アンタルヤに集中しています。イスタンブールには専門医療センターが最も多く集まっていますが、アンカラのクリニックでも包括的な医療を受けることができます。お客様の具体的な診断および治療計画に基づいた正確な費用については、専門医にご相談ください。
| トルコ | オーストリア | スペイン | |
| 高密度焦点式超音波焼灼術 | から $4,000 | から $12,000 | から $6,000 |
| 高周波焼灼術 | から $6,300 | から $15,000 | から $9,500 |
| 骨髄移植術 | から $36,000 | から $140,000 | から $71,782 |
| 陽子線治療 | から $70,000 | から $80,000 | から $25,061 |
| 腹腔鏡下腎摘出術 | から $12,830 | から $15,000 | から $12,000 |
Bookimedは腫瘍科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。腫瘍科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。腫瘍科治療の旅路でお一人になることはありません。
900件以上の腫瘍科処置 – Bülent Karagöz教授は、アナドル医療センターにて腫瘍生物学および免疫療法を専門としています。
トルコの腫瘍内科試験で第3位を獲得したタンルクル医師は、アナドル医療センターにて化学療法および免疫療法を専門としています。
タイフン・アプハン教授は200以上の学術論文を持ち、オハイオ州立大学にて頭頸部外科のトレーニングを受けました。
ムスタファ・ソラク医師は消化器癌を専門とし、ハジェテペ大学がん研究所およびMDアンダーソンがんセンター（腫瘍学の世界的権威）にて研鑽を積みました。
Oncology treatments in Turkey are safe and strictly regulated by the Ministry of Health. Hospitals must hold an International Health Tourism Status Certificate to treat foreign patients legally. Facilities like Anadolu Medical Center and Memorial Sisli hold Joint Commission International accreditation. This ensures clinical safety standards equivalent to those in the US.
Bookimed Expert Insight: Anadolu Medical Center in Istanbul is the only Turkish clinic affiliated with Johns Hopkins Hospital. This partnership means patients access American standard care protocols and technology. This includes the da Vinci XI robotic system for 30% to 50% less than in Australia.
Patient Consensus: Patients value the professional environment in Istanbul and Antalya. Surgeons personally explain complex procedures, while dedicated interpreters help keep the medical process clear and well-managed.
Turkish oncology centres report a 70% average five-year survival rate across all cancers. Breast cancer survival reaches 82.3% at five years. Strong results come from JCI-accredited facilities in major Istanbul hubs. These centres use technologies like CyberKnife, MR Linac, and the da Vinci robotic system.
Bookimed Expert Insight: Success in Turkey is driven by volume. Hospitals like Medipol Mega University Hospital treat 1,000,000 patients annually. This scale allows clinics to maintain multidisciplinary tumour boards. They also invest in rare tech like the EOS imaging device. High patient volumes typically lead to refined surgical techniques and faster diagnosis.
Patient Consensus: Patients note the speed of starting treatment and the meticulous doctors in Istanbul. Many highlight that having interpreters and personal coordinators makes the process feel secure.
Follow-up care in Australia transitions to a shared care model between GPs and local oncologists. This monitors for recurrence. Patients must provide complete English records, including pathology, surgical notes, and imaging. This helps Australian specialists align surveillance with national Optimal Care Pathways.
Bookimed Expert Insight: Turkish centres like Anadolu Medical Center provide patient coordinators. They provide English translations for all records before discharge. For those treated with CyberKnife, technical reports are vital for Australian surgeons. They show the exact surgical margins and radiation fields used.
Patient Consensus: Patients find having contact details for their Turkish oncologist helps local doctors during handover. Many suggest booking a GP appointment immediately upon returning home. This helps schedule scans and Medicare-subsidised blood tests without gaps in care.
Turkish oncology centres provide therapies including CyberKnife robotic radiosurgery and the da Vinci surgical system. Major Istanbul facilities also use MR Linac for real-time tumour tracking. Centres like Anadolu Medical Center and Medipol Mega University Hospital hold JCI accreditation. They offer integrated genomic profiling for targeted therapy.
Bookimed Expert Insight: Accuracy often depends on equipment speed. Digital PET/CT scanners in hospitals like Memorial Göztepe or Anadolu detect small lesions quickly. This allows oncologists to find tumours earlier. They can adjust treatment plans before cancer spreads to improve results.
Patient Consensus: Patients note that technologies like the da Vinci robot are explained clearly. Knowledgeable doctors and helpful translation services support the process. The efficiency at Turkish hospitals stands out. Results often arrive quickly to help manage the initial stress of a diagnosis.
International patients typically wait less than 1 week to start oncology treatment in private Turkish hospitals. Most clinics coordinate consultations within 48 hours of arrival. Diagnostics like PET-CT and MRI occur on Days 2 to 4. Specialised treatment protocols often begin by Day 7.
Bookimed Expert Insight: Clinics with high international volumes often have on-site pathology labs. An example is Anadolu Medical Center, which treats 65,000 patients annually. This setup prevents the typical 10-day wait for biopsy results seen in public systems. For Australian patients, a treatment plan is often finalised before the first week concludes.
Patient Consensus: Patients in Turkey report an efficient experience. Transportation, medical checks, and doctor consultations run smoothly. They frequently express relief at how quickly they progress from arrival to starting their treatment.
Most Turkish hospitals operate international departments that provide professional medical interpreters at no extra cost. These specialists accompany patients through every stage of oncology care. This covers initial consultations, imaging like PET-CT, and surgeries using the da Vinci robotic system.
Bookimed Expert Insight: Clinics with high international volumes often have teams trained in oncological terms. Anadolu Medical Center serves 65,000+ patients annually and uses such teams. These coordinators handle everything in-house. This prevents the need for patients to hire external translators. Choosing a hospital with an established international department ensures the translator understands specific drug names and staging metrics.
Patient Consensus: Patients in Turkey report that coordinators and interpreters stay by their side during every scan. They appreciate receiving clear explanations about treatments like immunotherapy or surgery. They feel secure knowing their questions are answered promptly in their own language.